Clinical Trial: Surgery

JAGUAR

Full Name

Objective Analysis to Gauge EVAR Outcomes Through Randomization

Description

Purpose

This study is intended for individuals who have an abdominal aortic aneurysm (a bulge in the aorta) caused by a weakening in the artery wall. Participation in this study would follow the standard of care treatment for this condition.

Description

The objective of this study is to collect safety, performance and effectiveness data on the ALTO Abdominal Stent Graft System for the endovascular treatment of infrarenal abdominal aortic aneurysms and evaluate real-world outcomes in comparison to commercially available comparator devices.

Eligibility

Inclusion Criteria

Inclusion Criteria-including but may not be limited to:

  1. Participant is an adult at least 21 years old
  2. Participant has an unruptured infrarenal abdominal aortic aneurysm -AAA
  3. Participant is able and willing to comply with all required follow-up exams

 

To Participate

Please contact the Network Office of Research and Innovation at 610-402-9543.

For additional information

Opens in new tabhttp://www.ClinicalTrials.gov. The National Clinical Trial number (NCT) is NCT05064540

Doctor(s) Running This Study

Specialties

  • Vascular and Endovascular Surgery

Area of focus i

  • Open and Endovascular Repair of Aortic Aneurysms
  • Endarterectomy and Stenting for Carotid Stenosis
  • Bypass and Endovascular Revascularization for Critical Lower Limb Ischemia

Affiliated with

LVPG Cliniciani

Accepting New Patients